Aemetis, Inc (NASDAQ:AMTX) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday.
According to Zacks, “Aemetis, Inc. is an advanced fuels and renewable chemicals company. It produces renewable chemicals and fuels using patented microbes and processes. Aemetis owns and operates an ethanol animal feed plant in California to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. The Company also built, owns, and operates a renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis, Inc. is headquartered in Cupertino, California. “
Separately, FBR & Co set a $2.00 price target on shares of Aemetis and gave the company a “hold” rating in a report on Tuesday, May 16th.
Shares of Aemetis (AMTX) traded down 0.81% during trading on Thursday, reaching $1.22. The company had a trading volume of 4,944 shares. Aemetis has a 12-month low of $1.01 and a 12-month high of $2.50. The company’s market cap is $24.03 million. The firm has a 50-day moving average of $1.40 and a 200-day moving average of $1.35.
COPYRIGHT VIOLATION WARNING: “Aemetis, Inc (NASDAQ:AMTX) Raised to Hold at Zacks Investment Research” was first posted by BNB Daily and is the property of of BNB Daily. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://www.baseball-news-blog.com/2017/07/20/aemetis-inc-nasdaqamtx-raised-to-hold-at-zacks-investment-research.html.
An institutional investor recently raised its position in Aemetis stock. Geneva Advisors LLC boosted its stake in shares of Aemetis, Inc (NASDAQ:AMTX) by 2.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,511,631 shares of the specialty chemicals company’s stock after buying an additional 32,400 shares during the period. Geneva Advisors LLC owned approximately 7.67% of Aemetis worth $1,950,000 as of its most recent filing with the SEC. 19.02% of the stock is owned by institutional investors and hedge funds.
Aemetis Company Profile
Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.
For more information about research offerings from Zacks Investment Research, visit Zacks.com